ENDOCRINE CONSULT / PEER REVIEWED

What’s New in Diabetes Management: Psychosocial Care

Author and Disclosure Information

 

References

CONCLUSION

As providers, we should be familiar with the evidence-based, validated tools available to identify the psychosocial comorbidities of diabetes. Screening and assessing patients for psychosocial/behavioral challenges should be performed at an initial visit, at periodic intervals, and whenever there is a change in disease, treatment, or life circumstances.

Health care alliances with behavioral/mental health providers who are knowledgeable about diabetes treatment and the psychosocial aspects of diabetes are key. Patient-centered care is essential to promote optimal medical outcomes and psychological well-being. As members of the health care team, we must be respectful and responsive to patient preferences, needs, and values; clinical decisions should be guided by patient values. If A1C is not at goal despite maximized medication therapy and lifestyle modification, consider identifying and addressing any psychosocial factors that may be involved.

Pages

Recommended Reading

Suspecting Pituitary Disorders: "What’s Next?"
Clinician Reviews
Managing the "Hot" Mess of Thyroiditis
Clinician Reviews
How to Investigate Thyroid Nodules Like A Pro
Clinician Reviews
Myth Buster: Adrenal “Fatigue”
Clinician Reviews
Hormone therapy may reduce depressive symptoms in early menopause
Clinician Reviews
Learn ‘four Ds’ approach to heart failure in diabetes
Clinician Reviews
The Gut Microbiome in Type 2 Diabetes
Clinician Reviews
PCOS may influence the diversity of the gut microbiome
Clinician Reviews
Abstract: Please don't give hormone therapy a D recommendation or state that "harms far outweigh benefits for prevention of chronic disease"
Clinician Reviews
Metabolic syndrome scoring system predicts CVD in type 2 diabetes
Clinician Reviews